Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-17-066819

Chief Operating Officer gave up 889 shares (to pay taxes)

  • Chief Operating Officer acquired 2,925 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Powala Christopher Chief Operating Officer 2017-12-15 Option exercise +1,300 132,865 D: show line 1 in the form
Powala Christopher Chief Operating Officer 2017-12-15 Shares withheld for taxes −395 $24.23 $9,571 132,470 D: show line 2 in the form
Powala Christopher Chief Operating Officer 2017-12-18 Option exercise +1,625 134,095 D: show line 3 in the form
Powala Christopher Chief Operating Officer 2017-12-18 Shares withheld for taxes −494 $24.12 $11,915 133,601 D: show line 4 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Powala Christopher Chief Operating Officer 2017-12-15 Option exercise · Restricted Stock Units −1,300 9,100 D: show line 5 in the form
Powala Christopher Chief Operating Officer 2017-12-18 Option exercise · Restricted Stock Units −1,625 3,250 D: show line 6 in the form
Loading xslF345X03/doc4.xml…